Novel treatment regimen yields promising response in advanced-phase chronic myeloid leukemia
According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML)—including both accelerated or ...
Sep 18, 2024
0
7